📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions. (2017)

First Author: Opriessnig T

Attributed to: Host responses underlying immunity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2016.11.085

PubMed Identifier: 27919634

Publication URI: http://europepmc.org/abstract/MED/27919634

Type: Journal Article/Review

Volume: 35

Parent Publication: Vaccine

Issue: 2

ISSN: 0264-410X